Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.22.4
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Cash flows from operating activities:    
Net income $ 2,004,860 $ 1,786,002
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 205,446 170,369
Loss on extinguishment of debt 13,286 0
Unrealized foreign exchange (gain) loss and other (18,896) 21,728
Asset impairment charges 9,905 5,962
Disposal of non-controlling interest 8,270 0
Stock-based compensation expense 73,387 52,982
Gain on sale of business (29,687) 0
Deferred income taxes (255,116) (371,228)
Changes in assets and liabilities, net of assets acquired and liabilities assumed in business acquisitions:    
Accounts receivable (495,720) (444,685)
Inventories (393,177) (239,890)
Other assets 30,546 2,243
Accounts payable 80,789 40,579
Deferred system revenue 34,587 145,856
Deferred service revenue 30,219 33,468
Other liabilities 401,136 471,209
Net cash provided by operating activities 1,699,835 1,674,595
Cash flows from investing activities:    
Net proceeds from sale of business 75,358 0
Business acquisitions, net of cash acquired (27,144) (37,986)
Capital expenditures (177,994) (133,856)
Purchases of available-for-sale securities (558,165) (525,840)
Proceeds from sale of available-for-sale securities 36,755 40,792
Proceeds from maturity of available-for-sale securities 353,391 372,953
Purchases of trading securities (37,583) (58,342)
Proceeds from sale of trading securities 39,482 59,914
Proceeds from other investments 1,020 795
Net cash used in investing activities (294,880) (281,570)
Cash flows from financing activities:    
Payment of debt issuance costs (6,515) 0
Proceeds from revolving credit facility 300,000 300,000
Repayment of debt (862,250) (300,000)
Common stock repurchases (444,853) (829,551)
Payment of dividends to stockholders (372,192) (321,950)
Issuance of common stock 33,908 36,912
Tax withholding payments related to vested and released restricted stock units (57,550) (52,287)
Contingent consideration payable and other, net (2,500) 0
Purchase of non-controlling interest (4,295) 0
Net cash used in financing activities (1,416,247) (1,166,876)
Effect of exchange rate changes on cash and cash equivalents (2,139) (3,702)
Net increase (decrease) in cash and cash equivalents (13,431) 222,447
Cash and cash equivalents at beginning of period 1,584,908 1,434,610
Cash and cash equivalents at end of period 1,571,477 1,657,057
Supplemental cash flow disclosures:    
Income taxes paid, net 394,464 226,943
Interest paid 73,851 76,771
Non-cash activities:    
Contingent consideration payable - financing activities (1,774) 14,663
Dividends payable - financing activities 3,941 3,737
Unsettled common stock repurchase - financing activities 15,975 5,999
Accrued purchases of land, property and equipment - investing activities $ 30,590 $ 18,504